429
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Non-contrast enhanced MRI for efficiency evaluation of high-intensity focused ultrasound in adenomyosis ablation

, , , , , , & show all
Article: 2295813 | Received 13 Jun 2023, Accepted 12 Dec 2023, Published online: 17 Jan 2024

References

  • Zhai J, Vannuccini S, Petraglia F, et al. Adenomyosis: mechanisms and pathogenesis. Semin Reprod Med. 2020;38(2-03):129–143. doi: 10.1055/s-0040-1716687.
  • Chen Q, Li YW, Wang S, et al. Clinical manifestations of adenomyosis patients with or without pain symptoms. J Pain Res. 2019;12:3127–3133. doi: 10.2147/JPR.S212117.
  • Harada T, Khine YM, Kaponis A, et al. The impact of adenomyosis on women’s fertility. Obstet Gynecol Surv. 2016;71(9):557–568. doi: 10.1097/OGX.0000000000000346.
  • Bachu VS, Kedda J, Suk I, et al. High-intensity focused ultrasound: a review of mechanisms and clinical applications. Ann Biomed Eng. 2021;49(9):1975–1991. doi: 10.1007/s10439-021-02833-9.
  • Marques ALS, Andres MP, Kho RM, et al. Is high-intensity focused ultrasound effective for the treatment of adenomyosis? A systematic review and meta-analysis. J Minim Invasive Gynecol. 2020;27(2):332–343. doi: 10.1016/j.jmig.2019.07.029.
  • Ou KY, Jeng CJ, Long CY, et al. A comparison of the cost-utility of ultrasound-guided high-intensity focused ultrasound and hysterectomy for adenomyosis: a retrospective study: is the cost-effectiveness of HIFU for adenomyosis and fibroids feasible? BJOG. 2018;125(6):763–764. doi: 10.1111/1471-0528.15115.
  • Fan TY, Zhang L, Chen W, et al. Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis. Eur J Radiol. 2012;81(11):3624–3630. doi: 10.1016/j.ejrad.2011.05.036.
  • Mindjuk I, Trumm CG, Herzog P, et al. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single Centre. Eur Radiol. 2015;25(5):1317–1328. doi: 10.1007/s00330-014-3538-6.
  • Keserci B, Duc NM. Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: retrospective multivariate analysis. Int J Hyperthermia. 2018;35(1):626–636. doi: 10.1080/02656736.2018.1516301.
  • Prince MR, Zhang H, Zou Z, et al. Incidence of immediate gadolinium contrast media reactions. AJR Am J Roentgenol. 2011;196(2):W138–W143. doi: 10.2214/AJR.10.4885.
  • Rogosnitzky M, Branch S. Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms. Biometals. 2016;29(3):365–376. doi: 10.1007/s10534-016-9931-7.
  • Laurent S, Elst LV, Copoix F, et al. Stability of MRI paramagnetic contrast media: a proton relaxometric protocol for transmetallation assessment. Invest Radiol. 2001;36(2):115–122. doi: 10.1097/00004424-200102000-00008.
  • Liao D, Xiao Z, Lv F, et al. Non-contrast enhanced MRI for assessment of uterine fibroids’ early response to ultrasound-guided high-intensity focused ultrasound thermal ablation. Eur J Radiol. 2020;122:108670. doi: 10.1016/j.ejrad.2019.108670.
  • Ikink ME, Voogt MJ, van den Bosch MA, et al. Diffusion-weighted magnetic resonance imaging using different b-value combinations for the evaluation of treatment results after volumetric MR-guided high-intensity focused ultrasound ablation of uterine fibroids. Eur Radiol. 2014;24(9):2118–2127. doi: 10.1007/s00330-014-3274-y.
  • Liu J, Wei J, Keserci B, et al. T2*-weighted imaging in the assessment of the non-perfused volume of uterine fibroids following magnetic resonance-guided high-intensity focused ultrasound ablation. Int J Gynaecol Obstet. 2016;132(1):100–102. doi: 10.1016/j.ijgo.2015.07.005.
  • Wu F, Chen WZ, Bai J, et al. Tumor vessel destruction resulting from high-intensity focused ultrasound in patients with solid malignancies. Ultrasound Med Biol. 2002;28(4):535–542. doi: 10.1016/s0301-5629(01)00515-4.
  • Gong C, Lin Z, Lv F, et al. Magnetic resonance imaging parameters in predicting the ablative efficiency of high-intensity focused ultrasound for uterine fibroids. Int J Hyperthermia. 2021;38(1):523–531. doi: 10.1080/02656736.2021.1904152.
  • Gong C, Yang B, Shi Y, et al. Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: a retrospective study. Int J Hyperthermia. 2016;32(5):496–503. doi: 10.3109/02656736.2016.1149232.
  • Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208. doi: 10.1038/nrc3672.
  • Willis WT, Jackman MR, Bizeau ME, et al. Hyperthermia impairs liver mitochondrial function in vitro. Am J Physiol Regul Integr Comp Physiol. 2000;278(5):R1240–R1246. doi: 10.1152/ajpregu.2000.278.5.R1240.
  • Harary M, Essayed WI, Valdes PA, et al. Volumetric analysis of magnetic resonance-guided focused ultrasound thalamotomy lesions. Neurosurg Focus. 2018;44(2):E6. doi: 10.3171/2017.11.FOCUS17587.
  • Walker MR, Zhong J, Waspe AC, et al. Acute MR-guided high-intensity focused ultrasound lesion assessment using diffusion-weighted imaging and histological analysis. Front Neurol. 2019;10:1069. doi: 10.3389/fneur.2019.01069.
  • Gomori JM, Grossman RI, Goldberg HI, et al. Intracranial hematomas: imaging by high-field MR. Radiology. 1985;157(1):87–93. doi: 10.1148/radiology.157.1.4034983.
  • Gomori JM, Grossman RI, Hackney DB, et al. Variable appearances of subacute intracranial hematomas on high-field spin-echo MR. Am J Roentgenol. 1988;150(1):171–178. doi: 10.2214/ajr.150.1.171.
  • Jacobs MA, Gultekin DH, Kim HS. Comparison between diffusion-weighted imaging, T2-weighted, and postcontrast T1-weighted imaging after MR-guided, high intensity, focused ultrasound treatment of uterine leiomyomata: preliminary results. Med Phys. 2010;37(9):4768–4776. doi: 10.1118/1.3475940.
  • Pilatou MC, Stewart EA, Maier SE, et al. MRI-based thermal dosimetry and diffusion-weighted imaging of MRI-guided focused ultrasound thermal ablation of uterine fibroids. J Magn Reson Imaging. 2009;29(2):404–411. doi: 10.1002/jmri.21688.